Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ · Healthcare
Oramed Pharmaceuticals Inc. Operating Income 2016–2025
Oramed Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2016 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Oramed Pharmaceuticals Inc. operating income for the quarter ending March 31, 2025 was -4.5 M, a 13.59% decrease year-over-year.
- Oramed Pharmaceuticals Inc. operating income for the twelve months ending March 31, 2025 was -21.7 M, a 49.63% decrease year-over-year.
- Oramed Pharmaceuticals Inc. annual operating income for 2025 was -15.1 M, a 4.32% decrease from 2023.
- Oramed Pharmaceuticals Inc. annual operating income for 2023 was -15.8 M, a 61.16% decrease from 2022.
- Oramed Pharmaceuticals Inc. annual operating income for 2022 was -40.6 M, a 67.60% increase from 2021.
- Oramed Pharmaceuticals Inc. annual operating income for 2021 was -24.2 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Oramed Pharmaceuticals Inc. Operating Income — FAQ
Oramed Pharmaceuticals Inc. (ORMP) operating income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Oramed Pharmaceuticals Inc.'s operating income?
Oramed Pharmaceuticals Inc. (ORMP) reported operating income of -$15M for fiscal 2025.
Where can I see ORMP's operating income history?
The chart and table above show Oramed Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.